# NIKE, Inc.: financial statements, quarterly

NKE · NYSE · CIK 320187 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends May 31

Pages: [Overview](/companies/nke.md) · [Financials](/companies/nke/financials.md) · [Filings](/companies/nke/filings.md) · [Insiders](/companies/nke/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nke/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [13.4](/filings/0000320187-25-000004.md) | [12.4](/filings/0000320187-25-000016.md) | [12.6 d](/filings/0000320187-26-000088.md) | [11.6](/filings/0000320187-25-000097.md) | [12.4](/filings/0000320187-25-000151.md) | [11.3](/filings/0000320187-26-000037.md) | [11.1 d](/filings/0000320187-26-000088.md) | [11.7](/filings/0000320187-26-000193.md) | [12.4](/filings/0000320187-25-000151.md) | [11.3](/filings/0000320187-26-000037.md) | [11.0 d](/filings/0000320187-26-000088.md) | [11.2](/filings/0000320187-26-000193.md) |
| Cost of revenue | $bn | [7.4](/filings/0000320187-25-000004.md) | [6.9](/filings/0000320187-25-000016.md) | [7.0 d](/filings/0000320187-26-000088.md) | [6.3](/filings/0000320187-25-000097.md) | [7.0](/filings/0000320187-25-000151.md) | [6.6](/filings/0000320187-26-000037.md) | [6.6 d](/filings/0000320187-26-000088.md) | [6.8](/filings/0000320187-26-000193.md) | [7.4](/filings/0000320187-25-000151.md) | [6.7](/filings/0000320187-26-000037.md) | [5.6 d](/filings/0000320187-26-000088.md) | [6.4](/filings/0000320187-26-000193.md) |
| Gross profit | $bn | [6.0](/filings/0000320187-25-000004.md) | [5.6](/filings/0000320187-25-000016.md) | [5.6 d](/filings/0000320187-26-000088.md) | [5.3](/filings/0000320187-25-000097.md) | [5.4](/filings/0000320187-25-000151.md) | [4.7](/filings/0000320187-26-000037.md) | [4.5 d](/filings/0000320187-26-000088.md) | [4.9](/filings/0000320187-26-000193.md) | [5.0](/filings/0000320187-25-000151.md) | [4.5](/filings/0000320187-26-000037.md) | [5.4 d](/filings/0000320187-26-000088.md) | [4.8](/filings/0000320187-26-000193.md) |
| Selling, general and administrative | $bn | [4.1](/filings/0000320187-25-000004.md) | [4.2](/filings/0000320187-25-000016.md) | [4.1 d](/filings/0000320187-26-000088.md) | [4.0](/filings/0000320187-25-000097.md) | [4.0](/filings/0000320187-25-000151.md) | [3.9](/filings/0000320187-26-000037.md) | [4.1 d](/filings/0000320187-26-000088.md) | [4.0](/filings/0000320187-26-000193.md) | [4.0](/filings/0000320187-25-000151.md) | [4.0](/filings/0000320187-26-000037.md) | [4.1 d](/filings/0000320187-26-000088.md) | [3.9](/filings/0000320187-26-000193.md) |
| Income tax | $bn | [0.3](/filings/0000320187-25-000004.md) | [0.2](/filings/0000320187-25-000016.md) | [0.2 d](/filings/0000320187-26-000088.md) | [0.3](/filings/0000320187-25-000097.md) | [0.3](/filings/0000320187-25-000151.md) | [0.1](/filings/0000320187-26-000037.md) | [0.1 d](/filings/0000320187-26-000088.md) | [0.2](/filings/0000320187-26-000193.md) | [0.2](/filings/0000320187-25-000151.md) | [0.1](/filings/0000320187-26-000037.md) | [0.3 d](/filings/0000320187-26-000088.md) | [0.2](/filings/0000320187-26-000193.md) |
| Net income | $bn | [1.6](/filings/0000320187-25-000004.md) | [1.2](/filings/0000320187-25-000016.md) | [1.5 d](/filings/0000320187-26-000088.md) | [1.1](/filings/0000320187-25-000097.md) | [1.2](/filings/0000320187-25-000151.md) | [0.8](/filings/0000320187-26-000037.md) | [0.2 d](/filings/0000320187-26-000088.md) | [0.7](/filings/0000320187-26-000193.md) | [0.8](/filings/0000320187-25-000151.md) | [0.5](/filings/0000320187-26-000037.md) | [1.1 d](/filings/0000320187-26-000088.md) | [0.7](/filings/0000320187-26-000193.md) |
| Diluted EPS | $ per share | [1.03](/filings/0000320187-25-000004.md) | [0.77](/filings/0000320187-25-000016.md) | not reported | [0.70](/filings/0000320187-25-000097.md) | [0.78](/filings/0000320187-25-000151.md) | [0.54](/filings/0000320187-26-000037.md) | not reported | [0.49](/filings/0000320187-26-000193.md) | [0.53](/filings/0000320187-25-000151.md) | [0.35](/filings/0000320187-26-000037.md) | not reported | [0.48](/filings/0000320187-26-000193.md) |
| Basic EPS | $ per share | [1.04](/filings/0000320187-25-000004.md) | [0.77](/filings/0000320187-25-000016.md) | not reported | [0.70](/filings/0000320187-25-000097.md) | [0.78](/filings/0000320187-25-000151.md) | [0.54](/filings/0000320187-26-000037.md) | not reported | [0.49](/filings/0000320187-26-000193.md) | [0.54](/filings/0000320187-25-000151.md) | [0.35](/filings/0000320187-26-000037.md) | not reported | [0.48](/filings/0000320187-26-000193.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [7.9](/filings/0000320187-24-000004.md) | [9.0](/filings/0000320187-24-000019.md) | [9.9](/filings/0000320187-25-000047.md) | [8.5](/filings/0000320187-24-000065.md) | [8.0](/filings/0000320187-25-000004.md) | [8.6](/filings/0000320187-25-000016.md) | [7.5](/filings/0000320187-26-000088.md) | [7.0](/filings/0000320187-25-000097.md) | [7.0](/filings/0000320187-25-000151.md) | [6.7](/filings/0000320187-26-000037.md) | [7.6](/filings/0000320187-26-000193.md) | [6.9](/filings/0000320187-26-000193.md) |
| Current assets | $bn | [24.6](/filings/0000320187-24-000004.md) | [24.8](/filings/0000320187-24-000019.md) | [25.4](/filings/0000320187-25-000047.md) | [25.0](/filings/0000320187-24-000065.md) | [25.0](/filings/0000320187-25-000004.md) | [24.6](/filings/0000320187-25-000016.md) | [23.4](/filings/0000320187-26-000088.md) | [23.9](/filings/0000320187-25-000097.md) | [24.0](/filings/0000320187-25-000151.md) | [23.2](/filings/0000320187-26-000037.md) | [24.6](/filings/0000320187-26-000193.md) | [23.7](/filings/0000320187-26-000193.md) |
| Total assets | $bn | [37.2](/filings/0000320187-24-000004.md) | [37.4](/filings/0000320187-24-000019.md) | [38.1](/filings/0000320187-25-000047.md) | [37.9](/filings/0000320187-24-000065.md) | [38.0](/filings/0000320187-25-000004.md) | [37.8](/filings/0000320187-25-000016.md) | [36.6](/filings/0000320187-26-000088.md) | [37.3](/filings/0000320187-25-000097.md) | [37.8](/filings/0000320187-25-000151.md) | [37.1](/filings/0000320187-26-000037.md) | [38.4](/filings/0000320187-26-000193.md) | [37.8](/filings/0000320187-26-000193.md) |
| Current liabilities | $bn | [9.0](/filings/0000320187-24-000004.md) | [9.0](/filings/0000320187-24-000019.md) | [10.6](/filings/0000320187-25-000047.md) | [10.6](/filings/0000320187-24-000065.md) | [11.2](/filings/0000320187-25-000004.md) | [11.2](/filings/0000320187-25-000016.md) | [10.6](/filings/0000320187-26-000088.md) | [10.9](/filings/0000320187-25-000097.md) | [11.6](/filings/0000320187-25-000151.md) | [10.8](/filings/0000320187-26-000037.md) | [12.5](/filings/0000320187-26-000193.md) | [11.4](/filings/0000320187-26-000193.md) |
| Long-term debt | $bn | [8.9](/filings/0000320187-24-000004.md) | [8.9](/filings/0000320187-24-000019.md) | [7.9](/filings/0000320187-25-000047.md) | [8.0](/filings/0000320187-24-000065.md) | [8.0](/filings/0000320187-25-000004.md) | [8.0](/filings/0000320187-25-000016.md) | [8.0](/filings/0000320187-26-000088.md) | [8.0](/filings/0000320187-25-000097.md) | [7.0](/filings/0000320187-25-000151.md) | [7.0](/filings/0000320187-26-000037.md) | [5.9](/filings/0000320187-26-000193.md) | [5.9](/filings/0000320187-26-000193.md) |
| Current portion of debt | $bn | [0.0](/filings/0000320187-24-000004.md) | [0.0](/filings/0000320187-24-000019.md) | [1.0](/filings/0000320187-25-000047.md) | [1.0](/filings/0000320187-24-000065.md) | [1.0](/filings/0000320187-25-000004.md) | [1.0](/filings/0000320187-25-000016.md) | [0.0](/filings/0000320187-26-000088.md) | not reported | [1.0](/filings/0000320187-25-000151.md) | [1.0](/filings/0000320187-26-000037.md) | [2.0](/filings/0000320187-26-000193.md) | [2.0](/filings/0000320187-26-000193.md) |
| Short-term borrowings | $bn | [0.0](/filings/0000320187-24-000004.md) | [0.0](/filings/0000320187-24-000019.md) | [0.0](/filings/0000320187-25-000047.md) | [0.0](/filings/0000320187-24-000065.md) | [0.0](/filings/0000320187-25-000004.md) | [0.0](/filings/0000320187-25-000016.md) | [0.0](/filings/0000320187-26-000037.md) | [0.0](/filings/0000320187-25-000097.md) | [0.0](/filings/0000320187-25-000151.md) | [0.0](/filings/0000320187-26-000037.md) | not reported | not reported |
| Shareholders' equity | $bn | [14.1](/filings/0000320187-25-000016.md) | [14.2](/filings/0000320187-25-000016.md) | [14.4](/filings/0000320187-26-000088.md) | [13.9](/filings/0000320187-25-000151.md) | [14.0](/filings/0000320187-26-000037.md) | [14.0](/filings/0000320187-26-000037.md) | [13.2](/filings/0000320187-26-000193.md) | [13.5](/filings/0000320187-26-000193.md) | [14.1](/filings/0000320187-26-000037.md) | [14.1](/filings/0000320187-26-000037.md) | [14.9](/filings/0000320187-26-000193.md) | [15.2](/filings/0000320187-26-000193.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q4 FY2024 (2024-05-31) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q4 FY2025 (2025-05-31) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q4 FY2026 (2026-05-31) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,817 d](/filings/0000320187-25-000004.md) | [2,059 d](/filings/0000320187-25-000016.md) | [2,619 d](/filings/0000320187-26-000088.md) | [394](/filings/0000320187-25-000097.md) | [1,049 d](/filings/0000320187-25-000151.md) | [1,792 d](/filings/0000320187-26-000037.md) | [463 d](/filings/0000320187-26-000088.md) | [222](/filings/0000320187-26-000193.md) | [579 d](/filings/0000320187-25-000151.md) | [430 d](/filings/0000320187-26-000037.md) | [1,637 d](/filings/0000320187-26-000088.md) | [135](/filings/0000320187-26-000193.md) |
| Capital expenditure | $m | [205 d](/filings/0000320187-25-000004.md) | [141 d](/filings/0000320187-25-000016.md) | [213 d](/filings/0000320187-26-000088.md) | [120](/filings/0000320187-25-000097.md) | [129 d](/filings/0000320187-25-000151.md) | [81.0 d](/filings/0000320187-26-000037.md) | [100 d](/filings/0000320187-26-000088.md) | [207](/filings/0000320187-26-000193.md) | [193 d](/filings/0000320187-25-000151.md) | [146 d](/filings/0000320187-26-000037.md) | [138 d](/filings/0000320187-26-000088.md) | [199](/filings/0000320187-26-000193.md) |
| Dividends paid | $m | [523 d](/filings/0000320187-25-000004.md) | [562 d](/filings/0000320187-25-000016.md) | [560 d](/filings/0000320187-26-000088.md) | [558](/filings/0000320187-25-000097.md) | [557 d](/filings/0000320187-25-000151.md) | [594 d](/filings/0000320187-26-000037.md) | [591 d](/filings/0000320187-26-000088.md) | [591](/filings/0000320187-26-000193.md) | [598 d](/filings/0000320187-25-000151.md) | [609 d](/filings/0000320187-26-000037.md) | [609 d](/filings/0000320187-26-000088.md) | [610](/filings/0000320187-26-000193.md) |
| Share repurchases | $m | [1,198 d](/filings/0000320187-25-000004.md) | [883 d](/filings/0000320187-25-000016.md) | [1,036 d](/filings/0000320187-26-000088.md) | [1,184](/filings/0000320187-25-000097.md) | [1,096 d](/filings/0000320187-25-000151.md) | [506 d](/filings/0000320187-26-000037.md) | [199 d](/filings/0000320187-26-000088.md) | [126](/filings/0000320187-26-000193.md) | [20.0 d](/filings/0000320187-25-000151.md) | [0.0 d](/filings/0000320187-26-000037.md) | [0.0 d](/filings/0000320187-26-000088.md) | [0.0](/filings/0000320187-26-000193.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-11-30) | Q3 FY2023 (2023-02-28) | Q1 FY2024 (2023-08-31) | Q2 FY2024 (2023-11-30) | Q3 FY2024 (2024-02-29) | Q1 FY2025 (2024-08-31) | Q2 FY2025 (2024-11-30) | Q3 FY2025 (2025-02-28) | Q1 FY2026 (2025-08-31) | Q2 FY2026 (2025-11-30) | Q3 FY2026 (2026-02-28) | Q1 FY2027 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,572](/filings/0000320187-24-000004.md) | [1,565](/filings/0000320187-24-000019.md) | [1,543](/filings/0000320187-24-000065.md) | [1,532](/filings/0000320187-25-000004.md) | [1,527](/filings/0000320187-25-000016.md) | [1,502](/filings/0000320187-25-000097.md) | [1,490](/filings/0000320187-25-000151.md) | [1,481](/filings/0000320187-26-000037.md) | [1,479](/filings/0000320187-26-000193.md) | [1,481](/filings/0000320187-25-000151.md) | [1,482](/filings/0000320187-26-000037.md) | [1,484](/filings/0000320187-26-000193.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 855,351,589 at 2015-07-17, from the cover of the [10-K filed 2015-07-23](/filings/0000320187-15-000113.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.